Related Experiment Video
Updated: Jul 20, 2026

07:34
FISH for Pre-implantation Genetic Diagnosis
Published on: February 23, 2011
Preimplantation genetic diagnosis: development and regulation
1New Zealand Bioethics Council.
Medicine and Law
|August 26, 2006
Summary
Pre-implantation genetic diagnosis (PGD) aids in preventing serious genetic disorders but raises ethical concerns regarding disability devaluation and potential exploitation of donor-conceived children for organ donation. This analysis explores PGD
Area of Science:
- Reproductive Medicine and Genetics
- Bioethics and Medical Law
- Pediatric Stem Cell Transplantation
Background:
- Pre-implantation genetic diagnosis (PGD) is an assisted reproductive technology used with in vitro fertilization (IVF) to screen embryos for serious genetic mutations or chromosomal abnormalities.
- While PGD is accepted for preventing serious inherited diseases, it faces ethical debates regarding potential devaluation of individuals with disabilities and non-medical sex selection.
- Emerging applications of PGD include creating Human Leukocyte Antigen (HLA)-matched donor children for stem cell transplants, raising complex ethical questions about lifelong donation obligations.
Purpose of the Study:
- To examine the ethical and legal implications of using PGD for creating HLA-matched donor children.
- To analyze the potential for exploitation of donor-conceived children and the adequacy of parental decision-making in such cases.
- To compare regulatory approaches in the UK and New Zealand regarding PGD and its ethical boundaries.
Main Methods:
- Ethical and legal analysis of PGD applications.
- Comparative review of regulatory frameworks (UK's HFEA vs. New Zealand).
- Discussion of parental decision-making conflicts and the need for independent oversight.
Main Results:
- The use of PGD for non-medical sex selection and creating donor children presents significant ethical challenges.
- The core ethical issue shifts from PGD itself to the potential for harvesting organs/tissues from a child, necessitating protective measures.
- Discrepancies exist in PGD regulations, with the UK being more permissive than New Zealand, highlighting a lack of consistent legislative frameworks.
Conclusions:
- There is a need for robust legal and ethical guidelines to protect children conceived via PGD for donation purposes.
- Independent authorities or courts may be better suited than parents for making critical decisions regarding a child's donation, especially when conflicts of interest arise.
- The constitutional basis for ethics committee policies in the absence of legislation requires scrutiny, particularly concerning PGD's evolving applications.
Related Concept Videos
What is Genetic Engineering?
Overview
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
Genomic Imprinting and Inheritance
Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...

